A MAJOR review has pitted three blockbuster fat jabs against each other – comparing weight lost and how long users were able ...
Cipla collaboration brings a second brand of tirzepatide, Yurpeak, to India, aiming to widen patient access for diabetes and ...
Cipla will market Eli Lilly’s diabetes and weight-loss drug Mounjaro as Yurpeak in India, enhancing accessibility and ...
Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...
Analysts say that while the deal is a positive for the stock, it has already been priced in and investors are now resorting ...
Oprah Daily on MSN
Semaglutide vs. Tirzepatide: What’s the Difference, How Much Do They Cost, and Which Might Be Right for You?
Side effects: Like semaglutide, tirzepatide’s most common side effects are nausea, diarrhea, vomiting, stomach pain, and ...
Pharmaceutical Technology on MSN
UK regulators seize illegal weight loss drugs amid global pricing shake-up
The MHRA's raid follows an uptick in the trade of illegal GLP-1RA drugs used for obesity and type 2 diabetes amid shortages ...
Eli Lilly struck a deal with Walmart to expand pick-up options for its weight-loss medications at the discounted pricing available through the LillyDirect platform.
October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...
Eli Lilly's rival Novo Nordisk plans to retail both Ozempic and Wegovy in India as diabetes and weight-loss drugs, respectively.| Business News ...
Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback